Koninklijke Philips NV (PHG) Stock Price Today
Aura AI Summary
Key Stats
- $26.21BMarket Cap
- 2,041,908Volume
- HealthSector
- $32.9152W High
- $23.8152W Low
- 86 DaysTypical Hold Time
- $32.57BEnterprise Value
- 3.81%Div Yield
- 100% Sell | 0% BuyTrading Activity
Track Koninklijke Philips NV (PHG) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Koninklijke Philips NV has traded between a low of $23.81 and a high of $32.91, highlighting its annual price range. Buy and sell Koninklijke Philips NV shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Most Recent News
Otto Group and Sereact deploy 25 AI robots to automate complex returns processing in logistics.
Otto Group and Sereact are introducing up to 25 AI-controlled dual-arm robots at Otto Group’s logistics center in Poland to automate the inspection and sorting of returned items. These robots use Sereact's Cortex Physical AI, powered by NVIDIA techno...

Silver's supply deficit and economic pressures boost case for long SLV position.
Three of the world's largest economies—China, Japan, and the U.S.—face unsustainable debt levels, with rising interest rates increasing debt servicing costs in Japan and the U.S. However, economic challenges like higher energy costs and a weakening U...

Medifast Q3 revenue falls 19%, board changes expected but core business remains weak amid market disruption
Medifast reported a 19.4% year-over-year revenue decline to $72 million in Q3 2026, with a significant drop in active earning coaches by 47%, despite higher revenue per coach. The company maintains a strong, cash-heavy balance sheet trading near liqu...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.